H. GIBOIN ET AL.
96
[4] P. Hennet and C. Harvey, “Anaerobes in Periodontal
Disease in the Dog: A Review,” Journal of Veterinary
Dentistry, Vol. 8, No. 2, 1991, pp. 18-21.
[5] P. Hennet and C. Harvey, “Spirochetes in Periodontal
Disease in the Dog: A Review,” Journal of Veterinary
Dentistry, Vol. 8, No. 3, 1991, pp. 16-17.
[6] P. Hennet and C. Harvey, “Natural Development of Pe-
riodontal Disease in the Dog: A Review of Clinical, Ana-
tomical and Histological Features,” Journal of Veterinary
Dentistry, Vol. 9, No. 3, 1992, pp. 13-19.
[7] L. Forner, T. Larsen, M. Kilian and P. Holmstrup, “Inci-
dence of Bacteremia after Chewing, Tooth Brushing and
Scaling in Individuals with Periodontal Inflammation,”
Journal of Clinical Periodontology, Vol. 33, No. 6, 2006,
pp. 401-407. doi:10.1111/j.1600-051X.2006.00924.x
[8] M. Nieves, P. Hartwig, J. Kinyon and D. Riedesel, “Bac-
terial Isolates from Plaque and from Blood during and af-
ter Routine Dental Procedures in Dogs,” Veterinary Sur-
gery, Vol. 26, No. 1, 1997, pp. 26-32.
doi:10.1111/j.1532-950X.1997.tb01459.x
[9] H. Horz and G. Conrads, “Diagnosis and Anti-Infective
Therapy of Periodontitis,” Expert Review of Anti-Infective
Therapy, Vol. 5, No. 4, 2007, pp. 703-715.
doi:10.1586/14787210.5.4.703
[10] L. DeBowes, D. Mosier, E. Logan, C. Harvey, S. Lowry
and D. Richardson, “Association of Periodontal Disease
and Histologic Lesions in Multiple Organs from 45
Dogs,” Journal of Veterinary Dentistry, Vol. 13, No. 2,
1996, pp. 57-60.
[11] Z. Pavlica, M. Petelin, P. Juntes, D. Erzen, D. Crossley
and U. Skaleric, “Periodontal Disease Burden and Patho-
logical Changes in Organs of Dogs,” Journal of Veteri-
nary Dentistry, Vol. 25, No. 2, 2008, pp. 97-105.
[12] M. Jorgensen, A. Aalam and J. Slots, “Periodontal An-
timicrobials—Finding the Right Solutions,” International
Dental Journal, Vol. 55, No. 1, 2005, pp. 3-12.
[13] M. Addy and M. Martin, “Systemic Antimicrobials in the
Treatment of Chronic Periodontal Diseases: A Dilemma,”
Oral Diseases, Vol. 9, No. S1, 2003, pp. 38-44.
doi:10.1034/j.1601-0825.9.s1.7.x
[14] F. Sgolastra, R. Gatto, A. Petrucci and A. Monaco, “Ef-
fectiveness of Systemic Amoxicillin/Metronidazole as
Adjunctive Therapy to Scaling and Root Planing in the
Treatment of Chronic Periodontitis: A Systematic Review
and Meta-Analysis,” Journal of Periodontology, Vol. 83,
No. 10, 2012, pp. 1257-1269.
doi:10.1902/jop.2012.110625
[15] A. Haffajee, S. Dibart, R. Kent and S. Socransky, “Clini-
cal and Microbiological Changes Associated with the Use
of 4 Adjunctive Systemically Administered Agents in the
Treatment of Periodontal Infections,” Journal of Clinical
Periodontology, Vol. 22, No. 8, 1995, pp. 618-627.
doi:10.1111/j.1600-051X.1995.tb00815.x
[16] AVDC, “Policy Statement: The Use of Antibiotics in Ve-
terinary Dentistry,” 2005.
http://avdc.org/Antibiotic_Use_April_2005.pdf
[17] J. Warrick, G. Inskeep, T. Yonkers, G. Stookey and T.
Ewing, “Effect of Clindamycin Hydrochloride on Oral
Malodor, Plaque, Calculus, and Gingivitis in Dogs with
Periodontitis,” Veterinary Therapeutics, Vol. 1, No. 1,
2000, pp. 5-16.
[18] K. Zetner, G. Pum, W. Rausch, X. Rausch-Fan and S.
Hung, “Effect of Clindamycin Hydrochloride on Gingival
Crevicular Fluid and Immune Mediators in Beagles,” Ve-
terinary Therapeutics, Vol. 3, No. 2, 2002, pp. 177-188.
[19] D. Nielsen, C. Walser, G. Kodan, R. D. Chaney, T.
Yonkers, J. D. VerSteeg, G. Elfring and J. Slots, “Effects
of Treatment with Clindamycin Hydrochloride on Pro-
gression of Canine Periodontal Disease after Ultrasonic
Scaling,” Veterinary Therapeutics, Vol. 1, No. 3, 2000,
pp. 150-158.
[20] M. R. Stegemann, J. Sherington and S. Blanchflower,
“Pharmacokinetics and Pharmacodynamics of Cefovecin
in Dogs,” Journal of Veterinary Pharmacology and The-
rapeutics, Vol. 29, No. 6, 2006, pp. 501-511.
doi:10.1111/j.1365-2885.2006.00801.x
[21] R. Six, J. Cherni, R. Chesebrough, D. Cleaver, C. J. Lin-
deman, G. Papp, et al., “Efficacy and Safety of Cefovecin
in Treating Bacterial Folliculitis, Abscesses, or Infected
Wounds in Dogs,” Journal of the American Veterinary
Medical Association, Vol. 233, No. 3, 2008, pp. 433-439.
doi:10.2460/javma.233.3.433
[22] M. R. Stegemann, N. Coati, C. A. Passmore and J. Sher-
ington, “Clinical Efficacy and Safety of Cefovecin in the
Treatment of Canine Pyoderma and Wound Infections,”
The Journal of Small Animal Practice, Vol. 48, No. 7,
2007, pp. 378-386.
doi:10.1111/j.1748-5827.2007.00363.x
[23] M. R. Stegemann, J. Sherington and C. Passmore, “The
Efficacy and Safety of Cefovecin in the Treatment of Fe-
line Abscesses and Infected Wounds,” The Journal of
Small Animal Practice, Vol. 48, No. 12, 2007, pp.
683-689. doi:10.1111/j.1748-5827.2007.00390.x
[24] R. Six, D. M. Cleaver, C. J. Lindeman, J. Cherni, R.
Chesebrough, G. Papp, et al., “Effectiveness and Safety
of Cefovecin Sodium, an Extended-Spectrum Injectable
Cephalosporin, in the Treatment of Cats with Abscesses
and Infected Wounds,” Journal of the American Veteri-
nary Medical Association, Vol. 234, No. 1, 2009, pp.
81-87. doi:10.2460/javma.234.1.81
[25] C. A. Passmore, J. Sherington and M. R. Stegemann,
“Efficacy and Safety of Cefovecin (Convenia) for the
Treatment of Urinary Tract Infections in Dogs,” Journal
of Small Animal Practice, Vol. 48, No. 3, 2007, pp.
139-144. doi:10.1111/j.1748-5827.2006.00231.x
[26] C. A. Passmore, J. Sherington and M. R. Stegemann,
“Efficacy and Safety of Cefovecin for the Treatment of
Urinary Tract Infections in Cats,” The Journal of Small
Animal Practi c e, Vol. 49, No. 6, 2008, pp. 295-301.
doi:10.1111/j.1748-5827.2008.00545.x
[27] VICH, “International Cooperation on Harmonisation of
Technical Requirements for Registration of Veterinary
Medicinal Products,” 2000.
http://www.vichsec.org/pdf/2000/Gl09_st7.pdf
[28] C. Harvey, L. Laster, F. Shofer and B. Miller, “Scoring
the Full Extent of Periodontal Disease in the Dog: De-
velopment of a Total Mouth Periodontal Score (Tmps)
System,” Journal of Veterinary Dentistry, Vol. 25, No. 3,
Copyright © 2012 SciRes. OJVM